Melanoma Molecular Diagnostics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Melanoma Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Melanoma Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Melanoma Molecular Diagnostics Overall Market Size
2.1 Global Melanoma Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Melanoma Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Melanoma Molecular Diagnostics Players in Global Market
3.2 Top Global Melanoma Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Melanoma Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Melanoma Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Melanoma Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Melanoma Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Melanoma Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Melanoma Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Melanoma Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Melanoma Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Melanoma Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Melanoma Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Melanoma Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Melanoma Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Melanoma Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Melanoma Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Melanoma Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Melanoma Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Melanoma Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Melanoma Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Melanoma Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Melanoma Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Melanoma Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Melanoma Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Melanoma Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Melanoma Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Melanoma Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Melanoma Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Melanoma Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Melanoma Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Melanoma Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Melanoma Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Melanoma Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Melanoma Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Melanoma Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Melanoma Molecular Diagnostics Market Size, 2018-2030
7 Melanoma Molecular Diagnostics Companies Profiles
7.1 Foundationmendicine
7.1.1 Foundationmendicine Company Summary
7.1.2 Foundationmendicine Business Overview
7.1.3 Foundationmendicine Melanoma Molecular Diagnostics Major Product Offerings
7.1.4 Foundationmendicine Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Foundationmendicine Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Melanoma Molecular Diagnostics Major Product Offerings
7.2.4 Novartis Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Mole
7.3.1 Mole Company Summary
7.3.2 Mole Business Overview
7.3.3 Mole Melanoma Molecular Diagnostics Major Product Offerings
7.3.4 Mole Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Mole Key News & Latest Developments
7.4 Berryoncology
7.4.1 Berryoncology Company Summary
7.4.2 Berryoncology Business Overview
7.4.3 Berryoncology Melanoma Molecular Diagnostics Major Product Offerings
7.4.4 Berryoncology Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Berryoncology Key News & Latest Developments
7.5 Gene+
7.5.1 Gene+ Company Summary
7.5.2 Gene+ Business Overview
7.5.3 Gene+ Melanoma Molecular Diagnostics Major Product Offerings
7.5.4 Gene+ Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Gene+ Key News & Latest Developments
7.6 Annoroad
7.6.1 Annoroad Company Summary
7.6.2 Annoroad Business Overview
7.6.3 Annoroad Melanoma Molecular Diagnostics Major Product Offerings
7.6.4 Annoroad Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Annoroad Key News & Latest Developments
7.7 Topgen
7.7.1 Topgen Company Summary
7.7.2 Topgen Business Overview
7.7.3 Topgen Melanoma Molecular Diagnostics Major Product Offerings
7.7.4 Topgen Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Topgen Key News & Latest Developments
7.8 Geneis
7.8.1 Geneis Company Summary
7.8.2 Geneis Business Overview
7.8.3 Geneis Melanoma Molecular Diagnostics Major Product Offerings
7.8.4 Geneis Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Geneis Key News & Latest Developments
7.9 Unitedgene
7.9.1 Unitedgene Company Summary
7.9.2 Unitedgene Business Overview
7.9.3 Unitedgene Melanoma Molecular Diagnostics Major Product Offerings
7.9.4 Unitedgene Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Unitedgene Key News & Latest Developments
7.10 Inmedi
7.10.1 Inmedi Company Summary
7.10.2 Inmedi Business Overview
7.10.3 Inmedi Melanoma Molecular Diagnostics Major Product Offerings
7.10.4 Inmedi Melanoma Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Inmedi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Melanoma Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Melanoma Molecular Diagnostics Market Drivers in Global Market
Table 3. Melanoma Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Melanoma Molecular Diagnostics in Global Market
Table 5. Top Melanoma Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Melanoma Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Melanoma Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Melanoma Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Melanoma Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Melanoma Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Melanoma Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Melanoma Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Melanoma Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Melanoma Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Melanoma Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Melanoma Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Foundationmendicine Company Summary
Table 31. Foundationmendicine Melanoma Molecular Diagnostics Product Offerings
Table 32. Foundationmendicine Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Foundationmendicine Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Melanoma Molecular Diagnostics Product Offerings
Table 36. Novartis Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Mole Company Summary
Table 39. Mole Melanoma Molecular Diagnostics Product Offerings
Table 40. Mole Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Mole Key News & Latest Developments
Table 42. Berryoncology Company Summary
Table 43. Berryoncology Melanoma Molecular Diagnostics Product Offerings
Table 44. Berryoncology Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Berryoncology Key News & Latest Developments
Table 46. Gene+ Company Summary
Table 47. Gene+ Melanoma Molecular Diagnostics Product Offerings
Table 48. Gene+ Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Gene+ Key News & Latest Developments
Table 50. Annoroad Company Summary
Table 51. Annoroad Melanoma Molecular Diagnostics Product Offerings
Table 52. Annoroad Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Annoroad Key News & Latest Developments
Table 54. Topgen Company Summary
Table 55. Topgen Melanoma Molecular Diagnostics Product Offerings
Table 56. Topgen Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Topgen Key News & Latest Developments
Table 58. Geneis Company Summary
Table 59. Geneis Melanoma Molecular Diagnostics Product Offerings
Table 60. Geneis Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Geneis Key News & Latest Developments
Table 62. Unitedgene Company Summary
Table 63. Unitedgene Melanoma Molecular Diagnostics Product Offerings
Table 64. Unitedgene Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Unitedgene Key News & Latest Developments
Table 66. Inmedi Company Summary
Table 67. Inmedi Melanoma Molecular Diagnostics Product Offerings
Table 68. Inmedi Melanoma Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Inmedi Key News & Latest Developments
List of Figures
Figure 1. Melanoma Molecular Diagnostics Segment by Type in 2022
Figure 2. Melanoma Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Melanoma Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Melanoma Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Melanoma Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Melanoma Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Melanoma Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Melanoma Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Foundationmendicine Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mole Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Berryoncology Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Gene+ Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Annoroad Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Topgen Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Geneis Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Unitedgene Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Inmedi Melanoma Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
